Nota: Os dados após 2018-09-14 são ainda temporários e poderão por isso ter o valor de Abertura errado até nova actualização... Mudar para Gráfico Estático de SCHERING PLOUGH C
SCHERING PLOUGH C - [Ticker: SGP]
Range 52 Semanas
[0,000 - 0,000]
Hora da Última Trade
2018-09-14 - 00:00:00
Price-Target 1 Ano
Bid / Ask
Volume Médio (3m)
Nota: Os dados podem apresentar atraso de alguns minutos.
Notícias sobre SCHERING PLOUGH C [SGP]: (ordenadas por relevância)
Array BioPharma Names Carrie S. Cox Chairman of its Board of ... Markets Insider Before joining Schering-Plough, Ms. Cox served as Executive Vice President and President of Pharmacia's Global Prescription Business, Senior Vice President of Pharmacia & Upjohn's Global Prescription Business, and as Vice President of Women's ...
Keytruda sales power Merck to quarterly beat Reuters (Reuters) - Drugmaker Merck & Co (MRK.N) reported better-than-expected first-quarter earnings on Tuesday, helped by a more than 150 percent rise in sales of blockbuster cancer drug Keytruda.
2018-2025 Interferon Biosimilar Market by Raw Materials, Labour ... Expert Herald (press release) (blog) Interferon Biosimilar Market Report contribute in analysing the growth factors in upcoming years. This report provides market overview which includes Product Category, Applications, Manufactures. This report research delivers region and country level ...
A pharmaceutical firm bets big on a cancer drug The Economist Merck's merger with another pharma firm, Schering-Plough, in 2009, had brought it an obscure new cancer drug. At first Merck's scientists were unimpressed and relegated the drug to a list of assets to be licensed out. There was widespread scepticism at ...
Hepatitis C: tackling the silent killer The Pharmaceutical Journal 1997: The first alpha interferon, Schering-Plough's Intron A (interferon alpha-2B), is approved for treatment of hepatitis C in the UK. 1999: European blood services begin screening blood with nucleic acid amplification testing (NAT), because it ...
Merck, Schering-Plough set to complete merger Reuters NEW YORK (Reuters) - Merck & Co (MRK.N) and Schering-Plough Corp SGP.N said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical industry in recent weeks. Pfizer Inc (PFE.
Motif Bio Appoints Stephanie Noviello, MD, MPH as Vice President ... GlobeNewswire (press release) In this position, she served as clinical lead for the hepatitis B and C and HIV portfolios. She previously worked at Schering-Plough Research Institute as a Director in Hepatology. Prior to working in industry, she was an Epidemic Intelligence Service ...
USA: Deutsche Firma soll Gift für Hinrichtungen geliefert haben Neue Presse Daten des US-Zolls zufolge lieferte VET Pharma die Medikamente an ein US-Schwesterunternehmen, die Intervet Schering-Plough Animal Health. Beide Firmen gehören zum US-Pharmariesen Merck Sharp & Dohme (MSD). Weitere Lieferungen sollen nach ...
Science Exchange Adds Allergan EVP & Chief R&D Officer David ... Business Wire (press release) PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, Inc. announced today that C. David Nicholson, Ph.D., EVP and Chief R&D Officer at Allergan, has joined the Science Exchange Board of Directors. Dr. Nicholson's experience includes over forty ...
What You Should Know About Ken Frazier, The CEO Who Just Quit ... Forbes Kenneth C. Frazier, the chairman and chief executive of the U.S. drug maker Merck, resigned from President Donald Trump's American Manufacturing Council on Monday morning, saying in a statement, ?As CEO of Merck and as a matter of personal conscience ...
Bristol/Medarex: A Transformational Acquisition Rooted In ... In Vivo Bristol's $2.4 billion buyout of Medarex in 2009 yielded value equivalent or greater to that realized in larger M&A transactions signed that year, such as Pfizer/Wyeth, Merck/Schering-Plough and Roche/Genentech. The deal made BMS a leader in ...
Esperion Announces the Appointment of Jeffrey Berkowitz to Board ... GlobeNewswire (press release) We are confident Jeff will provide important contributions to help us deliver on the promise of bringing our complementary, oral LDL-C lowering therapies to the millions of patients who are inadequately treated with, or unable to gain access to ...
Hampshire Down breeders annual awards evening https://farmweek.com/about-us/ They were awarded the Moneycarragh Trophy for Best Individual Male, Anniversary Crystal Rose Bowl for Best Female Show Team and the Schering Plough Trophy for team having gained most points at three shows. Peter was a little shocked and very ...